tokens: The anti-MM activity of TRAIL/Apo2L was confirmed in nu/xid/bg mice xenografted with human MM cells ; TRAIL ( 500 microg intraperitoneally daily for 14 days ) was well tolerated and significantly suppressed the growth of plasmacytomas .